Showing results (201-210 of 319) with videos related to
Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|February 4, 2023
Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysisSatya Das, Sharon Phillips, Cody L Lee, et al.Journal of Thoracic Disease|May 22, 2025
Comparison of clinicopathologic features and prognosis between surgically resected pulmonary large-cell neuroendocrine carcinoma and small-cell lung cancerYuke Mao, Hao Chang, Lu Wang, et al.Nature Medicine|January 25, 2025
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trialScott Kopetz, Takayuki Yoshino, Eric Van Cutsem, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case SeriesRahel Demisse, Neha Damle, Edward Kim, et al.Annals of Surgical Oncology|May 29, 2009
Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin CLaura A Lambert, Terri S Armstrong, J Jack Lee, et al.Clinical Colorectal Cancer|July 16, 2020
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall SurvivalAlexandre A Jácome, Bryan Kee, David Fogelman, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.Annals of Surgery|August 3, 2017
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver MetastasesYun Shin Chun, Guillaume Passot, Suguru Yamashita, et al.Cancers|January 25, 2025
The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal CancerDeepak Bhamidipati, Jay R Johnson, Kangyu Lin, et al.International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.Pageof 32